XML 19 R6.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common Shares
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Bausch Health Companies Inc. Shareholders' Equity
Noncontrolling Interest
Beginning Balance (in shares) at Dec. 31, 2017   348,700,000.0          
Beginning Balance at Dec. 31, 2017 $ 5,944 $ 10,090 $ 380 $ (2,725) $ (1,896) $ 5,849 $ 95
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)   500,000.0          
Common shares issued under share-based compensation plans   $ 13 (13)        
Share-based compensation 21   21     21  
Employee withholding taxes related to share-based awards (6)   (6)     (6)  
Net (loss) income (2,579)     (2,581)   (2,581) 2
Other comprehensive income 46       44 44 2
Ending Balance (in shares) at Mar. 31, 2018   349,200,000.0          
Ending Balance at Mar. 31, 2018 $ 4,635 $ 10,103 382 (4,097) (1,852) 4,536 99
Beginning Balance (in shares) at Dec. 31, 2018 349,871,102 349,900,000.0          
Beginning Balance at Dec. 31, 2018 $ 2,815 $ 10,121 413 (5,664) (2,137) 2,733 82
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)   2,000,000          
Common shares issued under share-based compensation plans 1 $ 30 (29)     1  
Share-based compensation 24   24     24  
Employee withholding taxes related to share-based awards (34)   (34)     (34)  
Net (loss) income (48)     (52)   (52) 4
Other comprehensive income $ 21       21 21  
Ending Balance (in shares) at Mar. 31, 2019 351,873,984 351,900,000.0          
Ending Balance at Mar. 31, 2019 $ 2,779 $ 10,151 $ 374 $ (5,716) $ (2,116) $ 2,693 $ 86